Aberdeen Group plc decreased its position in Xylem Inc. (NYSE:XYL - Free Report) by 60.1% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 159,330 shares of the industrial products company's stock after selling 239,736 shares during the quarter. Aberdeen Group plc owned 0.07% of Xylem worth $16,135,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in XYL. State Street Corp grew its holdings in shares of Xylem by 2.4% during the second quarter. State Street Corp now owns 11,444,669 shares of the industrial products company's stock worth $1,352,874,000 after purchasing an additional 270,972 shares during the last quarter. Pinnacle Associates Ltd. raised its holdings in shares of Xylem by 3.6% in the third quarter. Pinnacle Associates Ltd. now owns 274,578 shares of the industrial products company's stock valued at $27,807,000 after buying an additional 9,650 shares during the last quarter. Perpetual Ltd raised its holdings in shares of Xylem by 10.2% in the third quarter. Perpetual Ltd now owns 129,946 shares of the industrial products company's stock valued at $13,160,000 after buying an additional 11,993 shares during the last quarter. TD Waterhouse Canada Inc. raised its holdings in shares of Xylem by 1,922.6% in the second quarter. TD Waterhouse Canada Inc. now owns 46,034 shares of the industrial products company's stock valued at $5,400,000 after buying an additional 43,758 shares during the last quarter. Finally, XXEC Inc. acquired a new position in Xylem during the 2nd quarter worth about $850,841,000. Institutional investors and hedge funds own 87.96% of the company's stock.
Insider Activity at Xylem
In related news, Director D Koch acquired 11,000 shares of the business's stock in a transaction that occurred on Thursday, October 29th. The shares were acquired at an average cost of $89.60 per share, with a total value of $985,600.00. Following the transaction, the director owned 12,247 shares of the company's stock, valued at $1,097,331.20. The trade was a 882.12% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.32% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
XYL has been the topic of several research analyst reports. Royal Bank Of Canada decreased their price target on shares of Xylem from $135.00 to $125.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 28th. Jefferies Financial Group boosted their price objective on shares of Xylem from $145.00 to $150.00 and gave the stock a "buy" rating in a research report on Monday, August 24th. UBS Group dropped their price objective on shares of Xylem from $112.00 to $99.00 and set a "neutral" rating for the company in a research report on Thursday, October 29th. JPMorgan Chase & Co. downgraded Xylem from an "overweight" rating to a "neutral" rating and reduced their price objective for the stock from $118.00 to $90.00 in a report on Wednesday, October 28th. Finally, Mizuho set a $99.00 target price on shares of Xylem in a research report on Wednesday, October 28th. Nine research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat.com, Xylem presently has a consensus rating of "Hold" and an average price target of $121.31.
Get Our Latest Stock Report on Xylem
Xylem Stock Down 1.3%
Shares of NYSE XYL opened at $94.73 on Wednesday. Xylem Inc. has a 52-week low of $87.40 and a 52-week high of $146.55. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.02 and a current ratio of 1.39. The stock has a market cap of $21.73 billion, a P/E ratio of 20.96, a P/E/G ratio of 1.60 and a beta of 1.01. The firm has a 50 day moving average price of $101.80 and a 200 day moving average price of $114.91.
Xylem (NYSE:XYL - Get Free Report) last posted its earnings results on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing the consensus estimate of $1.45 by ($0.01). Xylem had a return on equity of 12.06% and a net margin of 11.94%. The firm had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.28 billion. During the same quarter last year, the business posted $1.37 earnings per share. The company's revenue for the quarter was down 3.0% on a year-over-year basis. Analysts expect that Xylem Inc. will post 5.45 EPS for the current year.
Xylem Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 22nd. Investors of record on Tuesday, November 24th will be issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date is Tuesday, November 24th. Xylem's dividend payout ratio (DPR) is presently 38.05%.
Xylem Company Profile
(
Free Report)
Xylem Inc. is a water technology company that develops equipment, software and services for managing water and wastewater. Its offerings include pumps and treatment systems, water-quality testing and analysis, smart meters, monitoring and control technologies, and services for detecting leaks and maintaining water infrastructure. The company serves water and wastewater utilities, industrial and commercial customers, and residential markets. Its technologies support the movement, treatment, testing and efficient use of water across municipal and industrial systems.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.